仙乐健康：拟发行H股股票并在香港联交所主板上市

Core Viewpoint - The company plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy and capital strength [1] Group 1 - The fourth meeting of the fourth board of directors is scheduled for January 8, 2026, to review the proposal for issuing H-shares [1] - The initiative aims to leverage international capital market advantages to improve the company's capital strength and overall competitiveness [1] - The company is currently in discussions with relevant intermediaries regarding the issuance and listing details, which are not yet finalized [1]